BSE filing, NSE: EMAMILTD. Summary written from the filing by ALFA Finder's alert engine.
Emami Ltd: key numbers
- Share price
- ₹387.00
- Market cap
- ₹16,893 Cr
- Revenue (annual)
- ₹3,780 Cr
- Net profit (annual)
- ₹775.3 Cr
- P/E (TTM)
- 22.7×Sector 40.6×
- Promoter holding
- 54.84%+0.00% QoQ
- FII holding
- 9.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emami Ltd
All →Emami Other Announcement
Emami Limited filed a list of four Key Managerial Personnel authorised to determine materiality of events under SEBI Listing Regulations. It is a routine compliance intimation with no financial or business event.
Emami Earnings Call Transcript: Key Takeaways
Headline revenue growth of 36% flatters the quarter: like-to-like growth was 24%, gross margin fell 520 bps, and PAT fell 3% on tax normalisation.
Emami Dividend
Emami Limited declared an interim dividend of Rs 5 per equity share for FY 2026-27 at its board meeting on 5 November 2026. The record date for the dividend is 13 November 2026.
Emami Results Update
Emami Limited reported robust Q2FY27 performance with consolidated revenue growing 36% to ₹1,088 crore. The Board also approved a first interim dividend of ₹5 per share.
- Value
- ₹1,088 Cr
Emami Q2 FY27 Results: Net Profit ₹145.5 Cr, Down 1.9% YoY
Emami Ltd reported revenue from operations of ₹1,088 Cr (+36.2% YoY) and net profit of ₹145.5 Cr (-1.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹145.5 Cr · -1.9% YoY
Emami Share Pledge
Diwakar Finvest disclosed a pledge of 21.40 lakh Emami shares and a release of 41 lakh shares under Regulation 31. The filing states no monetary value.
Other management change announcements
All →Jivial Industries Management Change
Jivial Industries appointed Shivam Dineshbhai Sakariya as Additional Non-Executive Independent Director effective 5 November 2026. The NRC recommended the appointment.
Dr. Agarwals Health Care Management Change
Dr Agarwals Health Care reports Mr. Amar Agarwal's redesignation from Chairman and Non-Executive Director to Executive Director, effective 1 November 2026. The change was approved at a board meeting held on 5 November 2026.
Texmaco Rail & Engineering Management Change
Texmaco Rail & Engineering has re-appointed Mr. Udyavar Vittal Kamath as an Executive Director (WTD) with effect from 1 February 2027 for a 12-month term. The filing is a Regulation 30 management change disclosure.
- Execution
- 12 months from 1 February 2027
Windlas Biotech Management Change
Windlass Biotech reports Mr. Ashok Kumar Windlass ceased as Executive Director, resigning for succession planning, effective 5 November 2026. He moves to Founder President, and Hitesh Windlass becomes Managing Director.
Panasonic Energy India Company Management Change
Panasonic Energy India's Company Secretary and Compliance Officer, Srishti Jain, has resigned effective 30 November 2026. The board accepted the resignation at its 5 November 2026 meeting.
Varvee Global Management Change
Varvee Global's statutory auditor, Pankaj R Shah & Associates, resigned with immediate effect on 5 November 2026, citing preoccupancy with other audit assignments. The filing is a mandatory Regulation 30 auditor-resignation disclosure with no monetary value.